Discrepancies in the European and US guidelines on recommendations for the use of enoxaparin and fondaparinux in the treatment of ACS is causing confusion, some clinicians have suggested. Heartwire
Carotid bruits detected by auscultation might serve as markers for heart disease, rather than detect carotid lesions and the subsequent risk of stroke, and could help select patients who would benefit from an aggressive treatment strategy for cardiovascular risk, according to the results of new study. Heartwire
According to a new study, carotid bruits detected by auscultation might serve as markers for heart disease but not as indicators of carotid lesions and the subsequent risk for stroke. Medscape Medical News
In this CME video lecture, Drs. Izzo and Giles explain the forces affecting hemodynamic patterns in hypertension and discuss potential therapeutic interventions to optimize flow. Medscape Cardiology
Molecular MRI allows use of labeled hematopoietic stem-progenitor cells to identify diffuse atherosclerosis. New techniques in molecular MRI of atherosclerosis and their potential applications in clinical practice are reviewed. Nature Clinical Practice Cardiovascular Medicine
Dr Jonathan Tobis argues that the FDA and the MHRA in the UK should step in to clear up the "mist of confusion" created by the disparate residual-shunt data reported officially and unofficially for MIST I. While the FDA is refusing to comment, the UK agency says it has reviewed the data and found no sign of safety or efficacy problems with the STARflex device. Heartwire
